OCT 25, 2020 10:05 PM PDT

Over 4 in 10 People With MS Have Used Cannabis in the Last Year

WRITTEN BY: Angela Dowden

University of Michigan researchers have found that Americans with Multiple sclerosis (MS) are twice as likely as the general US population to report using use cannabis or cannabinoid-based therapies.

According to the National Organization for the Reform of Marijuana Laws (NORML), 22.6 percent of US adults reported using marijuana within the last year, whereas the Michigan researchers found that 42 percent of people MS did so.

The study, “Cannabinoid use among Americans with MS: Current trends and gaps in knowledge,” was published in Multiple Sclerosis Journal – Experimental, Translational and Clinical. It set out to assess the prevalence and self-reported effectiveness of cannabinoid use among MS patients in the US, as well as the role played by healthcare providers in guiding patients on use of the drug.

Of the 1,217 survey respondents, a total of 1,027 answered the question about cannabis use in the past year. Among these, 427 (42 percent) endorsed cannabis use, of whom 386 (90 percent of this subgroup) said they used cannabis either strictly for medical purposes, or for both  medical and recreational purposes.

A striking finding was that only 1 percent of users said they had received assistance from their healthcare provider regarding selection of cannabinoid formulations.

Less that than one in five discussed use of cannabinoids with their healthcare provider at all.

The researchers found that MS patients who were affected more severely by pain, anxiety, depression, pain and sleep disturbances were those more likely to use cannabis products than those les affected.

On a scale of 0 to 10, where 0=no relief and 10=extreme relief, MS patients rated relief between 6.1 and 8 depending on symptom. Sleep problems and tremors were symptoms rated as most improved with cannabis.

Interestingly, where users expressed a preference for formulations with higher or lower concentrations of cannabidiol/tetrahydrocannibinol (CBD/THC) a significantly higher proportion of patients who used and liked THC-predominant formulations, experienced improvement in ability to fall asleep, and pain interfering with sleep (THC is the psychoactive component in cannabis).

The researchers wrote: ”Many Americans with MS use cannabinoids, and CBD-predominant products in particular, to self-manage a wide range of symptoms. These findings highlight crucial gaps between community use and clinical care, and illustrate an immediate need for prospective, mechanistic studies focused on the effects of cannabinoids for chronic MS symptoms, as well as interactions between MS symptoms.”

 

Sources: High Times, Multiple Sclerosis News Today

 

 

 

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
JAN 25, 2021
Cell & Molecular Biology
Beyond Organoids to a Better Research Model
JAN 25, 2021
Beyond Organoids to a Better Research Model
For many years, scientists have relied on cells that grow in dishes and animal models to learn more about human diseases ...
JAN 31, 2021
Microbiology
Does a Strain of Gut Bacteria Cause Parental Neglect?
JAN 31, 2021
Does a Strain of Gut Bacteria Cause Parental Neglect?
The gut microbiome is made up of a huge number of different microbial species, and scientists are learning more about ho ...
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
FEB 07, 2021
Genetics & Genomics
Insight Into a Disease-Related Protein in the Brain
FEB 07, 2021
Insight Into a Disease-Related Protein in the Brain
A protein called Gαo is found at high levels in the brain. Mutations in the gene that encodes Gαo cause dysfunctions in ...
FEB 06, 2021
Neuroscience
Chronic Depression Linked to Reduced Support Cell Function in Brain
FEB 06, 2021
Chronic Depression Linked to Reduced Support Cell Function in Brain
Researchers from Canada have found that people with chronic depression who ultimately commit suicide have significantly ...
MAR 03, 2021
Microbiology
Study May Explain Higher Flu Risk in Adults That Were Premature Babies
MAR 03, 2021
Study May Explain Higher Flu Risk in Adults That Were Premature Babies
Medical treatments for the care of premature babies have allowed many individuals to get through that challenge and lead ...
Loading Comments...